INTRODUCTION
============

Nontuberculous mycobacteria (NTM) are *Mycobacterium* spp. other than *M*. *leprae* and those that constitute the *M*. *tuberculosis* complex. NTM are widely distributed in nature, and some have been associated with human diseases that are characterized by pulmonary/extrapulmonary manifestations that are collectively known as nontuberculous mycobacterial infections. In addition to differences in virulence among NTM, several host factors play a determinant role in the development of clinical manifestations of pulmonary nontuberculous mycobacterial infection, including structural lung changes caused by previous tuberculosis, cystic fibrosis, COPD, silicosis, and pneumoconiosis, as well as conditions that affect the immune system, such as alcoholism, smoking, and treatment with immunosuppressive drugs.[@B1] ^-^ [@B3]

The diagnosis of pulmonary nontuberculous mycobacterial infection is highly complex and requires a combination of clinical, radiological, and microbiological findings, as established by the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) in 2007.[@B4] The clinical presentation of pulmonary nontuberculous mycobacterial infection is variable and nonspecific, and radiological features include cavitary and nodular lesions. The microbiological diagnosis of pulmonary nontuberculous mycobacterial infection involves the isolation and identification of the same NTM species in at least two sputum samples, one BAL fluid sample, or one lung biopsy sample. Although the ATS/IDSA did not specify the time interval between the first and second sputum sample collections in an official statement published in 2007,[@B4] it had previously been reported that a 12-month interval is required for positive culture results.[@B5]

Because pulmonary nontuberculous mycobacterial infections are difficult to diagnose and because reporting is not compulsory, it is difficult to establish epidemiological markers; however, evidence suggests that the prevalence of pulmonary nontuberculous mycobacterial infections has steadily increased in recent years.[@B3] ^,^ [@B6] The two NTM species that originally constituted the *M*. *avium complex* (MAC), namely *M*. *avium* and *M*. *intracellulare*,[@B7] as well as *M*. *abscessus*, are the NTM species that are most commonly associated with pulmonary nontuberculous mycobacterial infection worldwide, whereas others appear to be more common in certain geographic regions.[@B3] In Brazil, studies employing the ATS/IDSA criteria[@B4] have shown that the aforementioned species and *M*. *kansasii* are the most prevalent causes of pulmonary nontuberculous mycobacterial infection in the states of Rio de Janeiro[@B8] and Rio Grande do Sul.[@B9]

The frequency at which the various NTM species are identified in individuals with pulmonary nontuberculous mycobacterial infection has been determined on the basis of the ATS/IDSA microbiological criteria alone.[@B10] ^-^ [@B12] The present study is a retrospective analysis of the data on NTM species isolated from respiratory specimens in a referral laboratory in the state of São Paulo, Brazil, between 2011 and 2014. Our objective was to determine the frequency at which the various NTM species are identified among selected individuals and in potential cases of pulmonary nontuberculous mycobacterial infection on the basis of microbiological criteria.

METHODS
=======

The *Instituto Adolfo Lutz* (IAL, Adolfo Lutz Institute) is a referral laboratory in the state of São Paulo. In addition to the IAL headquarters (a referral center for tuberculosis and nontuberculous mycobacterial infections in the city of São Paulo, Brazil), there are twelve regional laboratories strategically located throughout the state of São Paulo. Mycobacterial cultures are performed in the regional laboratories and in approximately 80 others (either public laboratories or laboratories affiliated with the Brazilian Unified Health Care System), and all positive cultures are sent to the IAL headquarters for identification. All patient data provided by the regional laboratories and the results of isolate identification are recorded in a laboratory information management system (LIMS). For the present study, the results of isolate identification for the period between 2011 and 2014 were entered into Microsoft Excel 2007 spreadsheets (one for each year), data on NTM species isolated from respiratory specimens being subsequently selected and entered into a new Microsoft Excel 2007 spreadsheet.

In the new spreadsheet, the first record of each individual was selected in order to identify patients for inclusion in the study ("selected patients"), and new spreadsheets were created for each NTM species identified during the study period. Patient laboratory records were reviewed in order to identify patients meeting the requirements for analysis of the ATS/IDSA microbiological criteria for the diagnosis of pulmonary nontuberculous mycobacterial infection,[@B4] all data being entered into the aforementioned spreadsheets. Subsequently, spreadsheets were created for those who met the requirements for analysis of the ATS/IDSA diagnostic criteria ("analyzed patients") and those who had a presumptive diagnosis based on the microbiological criteria ("identified patients") for each NTM isolate.

All NTM species were identified by PCR-restriction enzyme analysis (PRA), which consists of amplification of a 441-bp fragment of the *hsp65* gene, followed by digestion of the amplified product with two restriction enzymes (BstEII and HaeIII) and analysis of the fragments separated by agarose gel electrophoresis. The various NTM species have different restriction patterns, which can be used for species identification by means of an algorithm.[@B13]

The present study was approved by the Technical and Scientific Advisory Committee and the Research Ethics Committee of the IAL (CTC no. 07-G/2014).

RESULTS
=======

Between 2011 and 2014, a total of 5,392 NTM were isolated from respiratory specimens from a total of 3,883 individuals. The *hsp65* PRA method failed to identify the NTM species in 881 patients (22.69%), isolates being phenotypically characterized as slowly growing mycobacteria (n = 630) or rapidly growing mycobacteria (n = 251). A restriction pattern suggestive of mixed culture (i.e., indicative of the presence of NTM and *M*. *tuberculosis* complex) was found in samples from 159 patients (4.09%). Therefore, 2,843 patients were selected for inclusion in the study.

Of the 2,843 patients selected for inclusion in the study, only 1,014 (35.67%) met the requirements for analysis of the ATS/IDSA microbiological criteria[@B4] for the diagnosis of pulmonary nontuberculous mycobacterial infection. A total of 50 species were identified, and [Table 1](#t1){ref-type="table"} shows the frequency at which they were identified among selected patients and analyzed patients. In both groups of patients, 6 NTM species were most common, the proportions for analyzed/selected patients being as follows, in descending order: *M*. *abscessus*, *M*. *kansasii*, *M*. *avium*, *M*. *fortuitum*, *M*. *intracellulare*, and *M*. *gordonae*.

Table 1Frequency and proportion of nontuberculous mycobacterial species among the patients selected for the study and those analyzed in relation to the microbiological criteria for the diagnosis of pulmonary nontuberculous mycobacterial infections in the state of São Paulo, Brazil, 2011-2014.SpeciesPatients, n (%)Analyzed/selected ratio, %SelectedAnalyzed(n = 2,843)(n = 1,014)*Mycobacterium avium*519 (18.26)198 (19.53)38.15*M. kansasii*453 (15.93)197 (19.43)43.49*M. intracellulare*423 (14.88)145 (14.30)34.28*M. gordonae*374 (13.16)97 (9.57)25.94*M. fortuitum*310 (10.90)117 (11.54)37.74*M. abscessus*219 (7.70)119 (11.74)54.34*M. peregrinum*143 (5.03)35 (3.45)24.48*M. chelonae*96 (3.38)19 (1.87)19.79*M. mucogenicum*66 (2.32)16 (1.58)24.24*M. lentiflavum*46 (1.62)9 (0.89)19.57*M. simiae*26 (0.91)7 (0.69)26.92*M. szulgai*19 (0.67)11 (1.08)57.89*M. asiaticum*16 (0.56)6 (0.59)37.50*M. florentinum*15 (0.53)1 (0.10)6.67*M. chitae*14 (0.49)4(0.39)28.57*M. goodii*14 (0.49)5 (0.49)35.71*M. nonchromogenicum*12 (0.42)6 (0.59)50.00*M. neoaurum*8 (0.28)2 (0.20)25.00*M. parascrofulaceum*8 (0.28)2 (0.20)25.00*M. novocastrense*7 (0.25)1 (0.10)14.29*M. xenopi*6 (0.21)3 (0.30)50.00*M. terrae*5 (0.18)1 (0.10)20.00*M. immunogenum*4 (0.14)1 (0.10)25.00*M. heidelbergense*3 (0.11)1 (0.10)33.33*M. kumamotonense*3 (0.11)1 (0.10)33.33*M. nebraskense*3 (0.11)3 (0.30)100.00*M. celatum*2 (0.07)1 (0.10)50.00*M. flavescens*2 (0.07)1 (0.10)50.00*M. gastri*2 (0.07)1 (0.10)50.00*M. parmense*2 (0.07)1 (0.10)50.00*M. sherrisii*2 (0.07)1 (0.10)50.00*M. brisbanense*2 (0.07)0-*M. monacense*2 (0.07)0-*M. triviale*2 (0.07)0-*M. genavense*1 (0.04)1 (0.10)100.00*M. triplex*1 (0.04)1 (0.10)100.00Others^a^13 (0.46)0-[^1]

As can be seen in [Table 2](#t2){ref-type="table"}, 448 (44.18%) of the 1,014 patients who were analyzed in relation to the microbiological criteria were identified as potential cases of pulmonary nontuberculous mycobacterial infection. The remaining 566 had one culture with NTM growth and, subsequently, no mycobacterial growth on culture. Among the patients who were identified as potential cases of pulmonary nontuberculous mycobacterial infection, the NTM species identified most frequently were *M*. *kansasii* (66.50%) and *M*. *abscessus* (64.71%), followed by *M*. *intracellulare* (60.69%) and *M*. *avium* (46.97%). *M*. *gordonae* and *M*. *fortuitum* were found in a considerable number of analyzed patients. However, among those who were identified as potential cases of pulmonary nontuberculous mycobacterial infection, they were found in only 20.62% and 13.68%, respectively.

Table 2Species of nontuberculous mycobacteria isolated from respiratory specimens from patients analyzed in relation to microbiological criteria for the diagnosis of pulmonary nontuberculous mycobacterial infections, as well as frequency of patients identified as potential cases of pulmonary nontuberculous mycobacterial infection in the state of São Paulo, Brazil, 2011-2014.SpeciesNumber of patientsAnalyzedIdentified%*Mycobacterium kansasii*19713166.50*M. abscessus*1197764.71*M. intracellulare*1458860.69*M. avium*1989346.97*M. szulgai*11545.45*M. peregrinum*35822.86*M. chelonae*19421.05*M. gordonae*972020.62*M. goodii*5120.00*M. simiae*7114.29*M. fortuitum*1171613.68*M. lentiflavum*9111.11Others^a^553^b^5.45Total1,01444844.18[^2]

A total of 19 NTM species were identified among the 568 patients who had only one positive culture (the others being negative) and who therefore were not presumptively diagnosed with pulmonary nontuberculous mycobacterial infection. The 19 NTM species identified were as follows: *M*. *asiaticum*, *M*. *chitae*, *M*. *flavescens*, *M*. *florentinum*, *M*. *gastri*, *M*. *genavense*, *M*. *goodii*, *M*. *heidelbergense*, *M*. *immunogenum*, *M*. *kumamotonense*, *M*. *mucogenicum*, *M*. *nebraskense*, *M*. *neoaurum*, *M*. *nonchromogenicum*, *M*. *novocastrense*, *M*. *parmense*, *M*. *terrae*, *M*. *triplex*, and *M*. *xenopi*.

DISCUSSION
==========

The identification of NTM species is extremely important because the clinical relevance and antimicrobial treatment of pulmonary nontuberculous mycobacterial infections are determined on the basis of the characteristics of the NTM species. Although the molecular method used in the present study (i.e., the *hsp65* PRA method) is more rapid and specific than phenotypic methods, some of its limitations include the fact that PCR inhibitors interfere with the sample and the fact that the available algorithm does not define the restriction patterns of the species. In the present study, the *hsp65* PRA method failed to identify the NTM isolates from 22.68% of the selected patients, the species being phenotypically characterized. Esparcia et al.[@B14] used the same algorithm that was used in the present study and reported that the *hsp65* PRA method failed to identify 32 (23.88%) of 134 NTM samples.

Although a wide variety of NTM species were identified in the present study, the most frequently identified species among selected and analyzed patients were, in descending order, *M*. *avium*, *M*. *kansasii*, *M*. *intracellulare*, *M*. *gordonae*, *M*. *fortuitum*, and *M*. *abscessus*. In a study conducted in the state of Rio Grande do Sul in the 2003-2013 period, the most frequently identified species were *M*. *avium*, *M*. *kansasii*, and *M*. *intracellulare*, followed by *M*. *abscessus*, *M*. *fortuitum*, and *M*. *gordonae*.[@B9] Between 1993 and 2011 in the state of Rio de Janeiro, the most frequently identified species was *M*. *kansasii*, followed by MAC, *M*. *abscessus*, and *M*. *fortuitum*.[@B8] It is of note that *M*. *abscessus* was the most frequently identified species among analyzed patients in the present study. This might be due to the fact that *M*. *abscessus* is resistant to many antimicrobial agents[@B3]-a fact that impedes patient clinical improvement-as well as to the fact that health professionals have limited knowledge of the relevance of *M*. *abscessus*.

Less than 40% of the selected patients in the present study met the requirements for analysis of the microbiological criteria for the diagnosis of pulmonary nontuberculous mycobacterial infection. This is probably due to the fact that the clinical specimens obtained after NTM identification were examined in laboratories where the IAL-LIMS is not used, screening therefore being impossible when the results were negative. However, in many patients for whom NTM cultures were performed in laboratories where the IAL-LIMS is used, no subsequent specimens were sent for analysis. This is probably due to loss to follow-up and a lack of knowledge on the part of the health care team regarding the need for multiple sputum examinations for laboratory diagnosis of pulmonary nontuberculous mycobacterial infection.

Given that NTM are widely distributed in nature, the isolation of NTM from a clinical specimen can represent colonization, infection, or pseudoinfection. Colonization is defined as the presence of NTM in the host microbiota without clinical manifestations, whereas infection is defined as the presence of NTM in the host microbiota with clinical manifestations. When neither colonization nor infection can be unequivocally confirmed, the possibility of pseudoinfection should be considered, pseudoinfection being usually caused by contamination during clinical specimen handling. There have been reports of outbreaks of nosocomial colonization and pseudoinfection with NTM primarily due to contaminated potable water supplies and inadequately disinfected medical equipment.[@B15]

In the present study, 14 NTM species led to a presumptive diagnosis of pulmonary nontuberculous mycobacterial infection based on microbiological criteria. The number of analyzed patients and the proportion of patients identified as potential cases of pulmonary nontuberculous mycobacterial infection were highest for the NTM species on which the ATS/IDSA criteria were based,[@B4] i.e., *M*. *avium*/*M*. *intracellulare* (MAC), *M*. *kansasii*, and *M*. *abscessus*. As in the present study, *M*. *fortuitum*, *M*. *peregrinum*, *M*. *chelonae*, and *M*. *szulgai* led to a presumptive diagnosis of pulmonary nontuberculous mycobacterial infection in a study conducted in Japan and employing microbiological criteria.[@B12] The fact that individuals with one positive culture[@B16] or more than one positive culture[@B17] for *M*. *fortuitum* were monitored for months and did not progress to lung disease was attributed to the fact that *M*. *fortuitum* is a low-virulence organism. *M*. *gordonae* is also considered to be a low-virulence strain and has been associated with several outbreaks of nosocomial mycobacterial pseudoinfection.[@B18]

Winthrop et al.[@B19] found that 183 (86%) of 214 patients with a presumptive diagnosis of pulmonary nontuberculous mycobacterial infection based on the ATS/IDSA microbiological criteria[@B4] had a confirmed diagnosis of pulmonary nontuberculous mycobacterial infection after analysis of clinical and radiological features, the authors having concluded that the ATS/IDSA microbiological criteria[@B4] are highly predictive of pulmonary nontuberculous mycobacterial infection. According to the ATS/IDSA, patients who are suspected of having pulmonary nontuberculous mycobacterial infection but do not meet the diagnostic criteria should be monitored until the diagnosis is firmly established or excluded.[@B4] Extensive clinical and laboratory monitoring of NTM isolates from clinical specimens obtained from patients with respiratory symptoms allows assessment of the relevance of NTM species, especially with regard to potential risk factors.

To our knowledge, ours is the first study in Brazil to determine the frequency at which the various NTM species are identified in a large number of individuals in a large geographic area rather than in a large number of respiratory specimens. The present study has limitations inherent to all retrospective studies, including missing information on patient medication use when multiple cultures are performed, the lack of which is minimized by innate NTM resistance to antimicrobials. Although various NTM species were identified in the individuals studied, those presumptively identified most frequently on the basis of the international microbiological criteria used in the state of São Paulo were the ones that are most commonly associated with pulmonary nontuberculous mycobacterial infection worldwide or in specific geographic regions. Health professionals should know more about pulmonary nontuberculous mycobacterial infections. There is a need for prospective multidisciplinary studies in which all of the diagnostic criteria established by the ATS/IDSA[@B4] are used and all of the characteristics of study participants are determined.
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[^1]: Thirteen species for which only one patient was selected: *M. arupense, M. aubagnense, M. branderi, M. brumae, M. conceptionense, M. farcinogenes, M. hiberniae, M. kubicae, M. montefiorense, M. scrofulaceum, M. senegalense, M. shimoidei*, and *M. wolinskyi*.

[^2]: Twenty-one species (for 15, only 1 or 2 patients were analyzed). ^b^ *M*. *celatum*, *M. parascrofulaceum*, and *M. sherrisii.*
